ADNT Adient plc - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
ADNT Stock | Fundamental Analysis & Investment Insights
NYSE
Consumer Cyclical
Auto Parts
Current Price
Live
$21.61
Analyst Target
$25.05
+15.9%
Upside
52W High
$26.16
52W Low
$10.04
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Jan 24, 2026
Market cap
$1.71B
P/E
N/A
ROE
-8.1%
Profit margin
-1.9%
Debt/Equity
1.23
Dividend yield
N/A
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
78%
Analysis Accuracy
The Advanced Deterministic Scorecard reveals critical weaknesses in Adient plc's financial health, with a Piotroski F-Score of just 2/9 indicating severe operational and profitability concerns. Despite a low forward P/E of 7.11 and a price/book below 1, suggesting potential value, the company is unprofitable (negative net margin and ROE), highly leveraged (Debt/Equity of 1.23), and experiencing sharply declining earnings (YoY EPS down 23.5%, earnings growth -76.6%). Insider selling, inconsistent earnings beats (only 1 of last 4 quarters), and weak long-term price performance (-47.7% over 3 years) further undermine confidence. While analysts recommend a 'buy' with a $25.05 target, the fundamental fragility outweighs near-term optimism.
Key Strengths
Low forward P/E ratio of 7.11 suggests potential undervaluation relative to earnings potential
Price-to-Book of 0.97 indicates shares trade below book value, a traditional value signal
Revenue growth remains positive at 3.5% YoY, showing top-line resilience
Operating margin of 3.58% indicates some cost control at operational level
Analyst consensus recommendation is 'buy' with a 15.5% upside to target price
Key Risks
Piotroski F-Score of 2/9 signals very weak financial health and high risk of distress
Negative profit margin (-1.93%) and ROE (-8.14%) indicate persistent unprofitability
High Debt/Equity ratio of 1.23 increases financial risk, especially in downturns
Earnings growth collapsing: YoY down 76.6%, Q/Q down 77.2%
Insiders are selling: $0.32M in sales over last 6 months with no buys
AI Fair Value Estimate
Based on comprehensive analysis
$18.5
-14.4% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
28
Weak
68
24
30
18
0
AI Verdict
High-risk turnaround play with speculative value appeal but weak fundamentals
Key drivers: Low valuation multiples, Negative earnings and profitability, Weak Piotroski score, Insider selling, Analyst optimism despite fundamentals
Confidence
80%
Value
68/100
Ref P/E, PEG, Graham Number
Positives
- Forward P/E of 7.11 is well below sector average of 56.39
- Price/Book of 0.97 suggests asset-backed floor
- Price/Sales of 0.12 is extremely low, indicating deep value
Watchpoints
- No Graham Number or intrinsic value provided
- P/E is misleading due to negative earnings (trailing P/E N/A)
Future
24/100
Ref Growth rates
Positives
- Revenue growth still positive at 3.5% YoY
- Most recent Q/Q EPS growth was +15.6%, a short-term rebound
Watchpoints
- Earnings growth YoY down 76.6%
- Q/Q earnings growth down 77.2%
- PEG ratio unavailable due to negative or volatile earnings
Past
30/100
Ref Historical trends
Positives
- Some history of large earnings surprises (e.g., +108.4% in Q3 2023)
- 1Y price return of +27.9% shows recent recovery
Watchpoints
- Only 1 of last 4 quarters beat estimates
- High earnings volatility and multiple large negative surprises
- 3Y price return down 47.7%, indicating long-term underperformance
Health
18/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Current ratio of 1.12 shows minimal short-term liquidity
- Operating margin positive at 3.58%
Watchpoints
- Piotroski F-Score of 2/9 indicates severe financial weakness
- ROE of -8.14% and negative net margin
- Quick ratio of 0.81 indicates potential liquidity stress
- Debt/Equity of 1.23 is high, especially for a cyclical sector
Dividend
0/100
Ref Yield, Payout
Positives
No standout positives identified.
Watchpoints
- Dividend Strength score of 0/100
- No dividend yield or payout history
- Payout ratio is 0%, but no actual dividend paid
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$21.61
Analyst Target
$25.05
Upside/Downside
+15.9%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for ADNT and closest competitors.
Updated 2026-01-23
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
ADNT
Adient plc
Primary
|
-36.0% | -47.7% | +27.9% | -4.9% | +11.6% | -1.9% |
|
AIN
Albany International Corp.
Peer
|
-20.0% | -45.0% | -27.5% | -19.5% | +12.4% | -0.5% |
|
ARCO
Arcos Dorados Holdings Inc.
Peer
|
+60.4% | -5.4% | +11.6% | +9.9% | +6.1% | +3.3% |
|
ACVA
ACV Auctions Inc.
Peer
|
-72.8% | -8.0% | -61.5% | -41.7% | +2.9% | -2.8% |
|
BH-A
Biglari Holdings Inc.
Peer
|
+361.4% | +231.2% | +131.1% | +55.9% | +29.8% | +2.3% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
N/A
Forward P/E
7.11
PEG Ratio
N/A
P/B Ratio
0.97
P/S Ratio
0.12
EV/Revenue
0.26
EV/EBITDA
4.99
Market Cap
$1.71B
Profitability
Profit margins and return metrics
Profit Margin
-1.93%
Operating Margin
3.58%
Gross Margin
6.81%
ROE
-8.14%
ROA
2.98%
Growth
Revenue and earnings growth rates
Revenue Growth
+3.5%
Earnings Growth
-76.6%
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
-77.2%
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
1.23
Moderate
Current Ratio
1.12
Good
Quick Ratio
0.81
Poor
Cash/Share
$12.1
Quarterly Earnings History
EPS performance vs analyst estimates
2026-02-04
$N/A
2025-11-05
$0.52
-7.3% surprise
2025-08-06
$0.45
-6.9% surprise
2025-05-07
$0.69
+111.6% surprise
Consumer Cyclical Sector Comparison
Comparing ADNT against 94 companies in the Consumer Cyclical sector
(6 bullish, 49 neutral, 39 bearish)
Return on Equity (ROE)
-8.14%
This Stock
vs
6.27%
Sector Avg
-229.9%
(Below Avg)
Profit Margin
-1.93%
This Stock
vs
0.86%
Sector Avg
-326.0%
(Weaker)
Debt to Equity
1.23
This Stock
vs
1.65
Sector Avg
-25.3%
(Less Debt)
Revenue Growth
3.5%
This Stock
vs
7.65%
Sector Avg
-54.2%
(Slower)
Current Ratio
1.12
This Stock
vs
1.86
Sector Avg
-39.9%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
ADNT
Adient plc
|
BEARISH | $1.71B | - | -8.1% | -1.9% | $21.61 | |
|
AIN
Albany International Corp.
|
BEARISH | $1.7B | - | -6.1% | -4.7% | $57.56 | |
|
ARCO
Arcos Dorados Holdings Inc.
|
NEUTRAL | $1.64B | 6.71 | 39.0% | 5.4% | $7.78 | |
|
ACVA
ACV Auctions Inc.
|
NEUTRAL | $1.54B | - | -16.3% | -9.9% | $8.5 | |
|
BH-A
Biglari Holdings Inc.
|
BEARISH | $1.51B | 227.28 | 0.4% | 0.5% | $2434.13 |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-31 | DORLACK JEROME J | Chief Executive Officer | Stock Award | 14,866 | - |
| 2025-11-26 | BERTHELIN MICHEL PIERRE ROSE | Officer | Sale | 2,500 | $49,275 |
| 2025-11-17 | HUANG JIAN JAMES | Officer | Stock Award | 3,667 | - |
| 2025-11-14 | HUANG JIAN JAMES | Officer | Stock Award | 73,900 | - |
| 2025-11-13 | DORLACK JEROME J | Chief Executive Officer | Stock Award | 220,324 | - |
| 2025-11-13 | BERTHELIN MICHEL PIERRE ROSE | Officer | Stock Award | 4,685 | - |
| 2025-11-13 | SMITH GREGORY SCOTT | Officer | Stock Award | 9,889 | - |
| 2025-11-13 | TILTMANN HEATHER M | Officer | Stock Award | 49,589 | - |
| 2025-11-13 | CONKLIN JAMES D. | Officer | Stock Award | 52,543 | - |
| 2025-11-13 | OSWALD MARK A. | Chief Financial Officer | Stock Award | 60,848 | - |
| 2025-11-13 | MARIANOS STEPHANIE S | Officer | Stock Award | 30,115 | - |
| 2025-08-07 | DORLACK JEROME J | Chief Executive Officer | Sale | 12,000 | $273,240 |
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
BUY
10 analysts
Stifel
2026-01-23
Buy
Buy
Barclays
2026-01-23
Equal-Weight
Equal-Weight
UBS
2026-01-14
Neutral
Buy
Wells Fargo
2026-01-12
Overweight
Overweight
Morgan Stanley
2025-12-08
Underweight
Equal-Weight
Citigroup
2025-11-12
Neutral
Neutral
Barclays
2025-11-07
Equal-Weight
Equal-Weight
JP Morgan
2025-11-06
Neutral
Neutral
UBS
2025-11-06
Neutral
Neutral
Wells Fargo
2025-11-06
Overweight
Overweight
Past News Coverage
Recent headlines mentioning ADNT from our newsroom.
Newest → oldest
No matching news yet.